[1]
Crook H, Raza S, Nowell J, et al. Long covid-mechanisms, risk factors, and management. BMJ 2021; 374(1648)
[http://dx.doi.org/10.1136/bmj.n.1648]
[http://dx.doi.org/10.1136/bmj.n.1648]
[2]
Venturelli S, Benatti S, Casati M, et al. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect 2021; 149e32
[http://dx.doi.org/10.1017/S0950268821000145]
[http://dx.doi.org/10.1017/S0950268821000145]
[3]
Yan Z, Yang M, Lai C. Long COVID-19 Syndrome: A Comprehensive Review of its Effect on Various Organ Systems and Recommendation on Rehabilitation Plans. Biomedicines 2021; 9(8): 966.
[http://dx.doi.org/10.3390/biomdicines9080966]
[http://dx.doi.org/10.3390/biomdicines9080966]
[4]
Mo X, Jian W, Su Z, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J 2020; 55(6)2001217 10.118313993003.01217-2020
[5]
Huang C, Huang L, Wang Y, et al. 6-month consequences ofCOVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397(10270): 220-32.
[http://dx.doi.org/10.1016/S0140-6736(20)32656-8]
[http://dx.doi.org/10.1016/S0140-6736(20)32656-8]
[6]
Bellan M, Baricich A, Patrucco F, et al. Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19. Sci Rep 2021; 11(1): 22666.
[http://dx.doi.org/10.1038/s41598-021-01215-4]
[http://dx.doi.org/10.1038/s41598-021-01215-4]
[7]
Qin W, Chen S, Zhang Y, et al. Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur Respir J 2021; 58(1)2003677
[http://dx.doi.org/10.1183/13993003.03677-2020]
[http://dx.doi.org/10.1183/13993003.03677-2020]
[8]
Steinbeis F, Thibeault C, Doellinger F, et al. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months. Respir Med 2022; 191106709
[http://dx.doi.org/10.1016/j.rmed.2021.106709]
[http://dx.doi.org/10.1016/j.rmed.2021.106709]
[9]
Fan B, Umapathi T, Chua K, et al. Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients. J Thromb Thrombolysis 2021; 51(4): 971-7.
[http://dx.doi.org/10.1007/s11239-020-02332-z]
[http://dx.doi.org/10.1007/s11239-020-02332-z]
[10]
Dhawan R, Gopalan D, Howard L, et al. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med 2021; 9(1): 107-16.
[http://dx.doi.org/10.1016/S2213-2600(20)30407-0]
[http://dx.doi.org/10.1016/S2213-2600(20)30407-0]
[11]
Schaefer W, Knollmann D, Meyer P. V/Q SPECT/CT in the Time of COVID-19: Changing the Order to Improve Safety Without Sacrificing Accuracy. J Nucl Med 2021; 62(7): 1022-4.
[http://dx.doi.org/10.2967/jnumed.120.261263]
[http://dx.doi.org/10.2967/jnumed.120.261263]
[12]
Clavario P, De Marzo V, Lotti R, et al. Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up. Int J Cardiol 2021; 340: 113-8.
[http://dx.doi.org/10.1016/j.ijcard.2021.07.033]
[http://dx.doi.org/10.1016/j.ijcard.2021.07.033]
[13]
Inui S, Gonoi W, Kurokawa R, et al. The role of chest imaging in the diagnosis, management, and monitoring of coronavirus disease 2019 (COVID-19). Insights Imaging 2021; 12(1): 155.
[http://dx.doi.org/10.1186/s13244-021-01096-1]
[http://dx.doi.org/10.1186/s13244-021-01096-1]
[14]
Tiralongo F, Palermo M, Distefano G, et al. Cryptogenic Organizing Pneumonia: Evolution of Morphological Patterns Assessed by HRCT. Diagnostics (Basel) 2020; 10(5): 262.
[http://dx.doi.org/10.3390/diagnostics10050262]
[http://dx.doi.org/10.3390/diagnostics10050262]
[15]
Marazzato J, De Ponti R, Verdecchia P, et al. Combined Use of Electrocardiography and Ultrasound to Detect Cardiac and Pulmonary Involvement after Recovery from COVID-19 Pneumonia: A Case Series. J Cardiovasc Dev Dis 2021; 8(10): 133.
[http://dx.doi.org/10.3390/jcdd8100133]
[http://dx.doi.org/10.3390/jcdd8100133]
[16]
Giovannetti G, De Michele L, De Ceglie M, et al. Lung ultrasonography for long-term follow-up of COVID-19 survivors compared to chest CT scan. Respir Med 2021; 181106384
[http://dx.doi.org/10.1016/j.rmed.2021.106384]
[http://dx.doi.org/10.1016/j.rmed.2021.106384]
[17]
Heiss R, Grodzki DM, Horger W, et al. High-performance low field MRI enables visualization of persistent pulmonary damage after COVID-19. Magn Reson Imaging 2021; 76: 49-51.
[http://dx.doi.org/10.1016/j.mri.2020.11.004]
[http://dx.doi.org/10.1016/j.mri.2020.11.004]
[18]
Yeh R, Elsakka A, Wray R, et al. FDG PET/CT imaging features and clinical utility in COVID-19. Clin Imaging 2021; 80: 262-7.
[http://dx.doi.org/10.1016/j.clinimag.2021.08.002]
[http://dx.doi.org/10.1016/j.clinimag.2021.08.002]
Related Journals
Article Metrics
9